annual CAPEX:
N/ASummary
- DNLI annual capital expenditures is not available.
Performance
DNLI CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
quarterly CAPEX:
N/ASummary
- DNLI quarterly capital expenditures is not available.
Performance
DNLI quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
TTM CAPEX:
N/ASummary
- DNLI TTM capital expenditures is not available.
Performance
DNLI TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
DNLI CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
DNLI CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
DNLI CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $12.94M(-27.4%) | - | - |
| Sep 2023 | - | $2.07M(-64.6%) | $15.55M(-20.4%) |
| Jun 2023 | - | $5.85M(+110.0%) | $19.54M(+17.8%) |
| Mar 2023 | - | $2.79M(-42.5%) | $16.58M(-7.0%) |
| Dec 2022 | $17.83M(+109.8%) | $4.85M(-19.9%) | $17.83M(+11.2%) |
| Sep 2022 | - | $6.05M(+109.1%) | $16.04M(+35.2%) |
| Jun 2022 | - | $2.89M(-28.4%) | $11.86M(+21.8%) |
| Mar 2022 | - | $4.04M(+32.4%) | $9.74M(+14.6%) |
| Dec 2021 | $8.50M(+174.6%) | $3.05M(+62.8%) | $8.50M(+28.0%) |
| Sep 2021 | - | $1.88M(+142.9%) | $6.64M(+21.4%) |
| Jun 2021 | - | $772.00K(-72.4%) | $5.47M(+9.1%) |
| Mar 2021 | - | $2.80M(+134.3%) | $5.02M(+62.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $3.10M(-82.7%) | $1.20M(+69.3%) | $3.10M(-33.8%) |
| Sep 2020 | - | $706.00K(+124.1%) | $4.67M(-31.4%) |
| Jun 2020 | - | $315.00K(-64.2%) | $6.81M(-59.4%) |
| Mar 2020 | - | $879.00K(-68.3%) | $16.77M(-6.4%) |
| Dec 2019 | $17.92M(+428.1%) | $2.77M(-2.6%) | $17.92M(+8.1%) |
| Sep 2019 | - | $2.85M(-72.3%) | $16.58M(+13.7%) |
| Jun 2019 | - | $10.27M(+406.5%) | $14.58M(+198.6%) |
| Mar 2019 | - | $2.03M(+41.1%) | $4.88M(+43.9%) |
| Dec 2018 | $3.39M | $1.44M(+69.7%) | $3.39M(+73.5%) |
| Sep 2018 | - | $847.00K(+48.1%) | $1.96M(+76.4%) |
| Jun 2018 | - | $572.00K(+6.5%) | $1.11M(+106.5%) |
| Mar 2018 | - | $537.00K | $537.00K |
FAQ
- What is the all time high annual CAPEX for Denali Therapeutics?
- What is the all time high quarterly CAPEX for Denali Therapeutics?
- What is the all time high TTM CAPEX for Denali Therapeutics?
What is the all time high annual CAPEX for Denali Therapeutics?
Denali Therapeutics all-time high annual capital expenditures is $17.92M
What is the all time high quarterly CAPEX for Denali Therapeutics?
Denali Therapeutics all-time high quarterly capital expenditures is $10.27M
What is the all time high TTM CAPEX for Denali Therapeutics?
Denali Therapeutics all-time high TTM capital expenditures is $19.54M